pentoxifylline has been researched along with Bone Loss, Osteoclastic in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Osteoporosis was measured by in vivo neutron activation analysis and results were confirmed by atomic absorption spectroscopy." | 1.27 | Studies on osteoporoses. XI. Effects of a methylxanthine derivative. A preliminary report. ( Ambrus, JL; Robin, JC, 1983) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pal, S | 1 |
Porwal, K | 1 |
Khanna, K | 1 |
Gautam, MK | 1 |
Malik, MY | 1 |
Rashid, M | 1 |
Macleod, RJ | 1 |
Wahajuddin, M | 1 |
Parameswaran, V | 1 |
Bellare, JR | 1 |
Chattopadhyay, N | 1 |
Robin, JC | 1 |
Ambrus, JL | 1 |
2 other studies available for pentoxifylline and Bone Loss, Osteoclastic
Article | Year |
---|---|
Oral dosing of pentoxifylline, a pan-phosphodiesterase inhibitor restores bone mass and quality in osteopenic rabbits by an osteogenic mechanism: A comparative study with human parathyroid hormone.
Topics: Administration, Oral; Animals; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Cells, Cultu | 2019 |
Studies on osteoporoses. XI. Effects of a methylxanthine derivative. A preliminary report.
Topics: Animals; Bone Resorption; Calcium; Cyclic AMP; Female; Heparin; Mice; Mice, Inbred C3H; Neutron Acti | 1983 |